ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 573,06
-0,78%
Dow Jones
40 211,72
0,53%
DAX
18 475,77
-0,67%
Brent Oil
83,58
-0,90%
Bitcoin
62 606,97
-3,46%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intellia Therapeutics Inc (NTLA)

  7. Intellia Therapeutics Inc (NTLA) Actualités

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateHeureSourceTitreSymboleSociété
30/07/201914h00GlobeNewswire Inc.Intellia Therapeutics to Present at August Healthcare Investor ConferenceNASDAQ:NTLAIntellia Therapeutics Inc
25/07/201913h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
09/07/201914h54Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTLAIntellia Therapeutics Inc
07/06/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NTLAIntellia Therapeutics Inc
04/06/201922h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
30/05/201922h30GlobeNewswire Inc.Intellia Therapeutics to Participate at June Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
29/05/201922h25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
28/05/201913h50GlobeNewswire Inc.Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific OfficerNASDAQ:NTLAIntellia Therapeutics Inc
22/05/201922h38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
09/05/201918h52Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201923h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201922h19Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201913h30GlobeNewswire Inc.Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
29/04/201913h30GlobeNewswire Inc.Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Societ...NASDAQ:NTLAIntellia Therapeutics Inc
25/04/201913h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
16/04/201922h32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NTLAIntellia Therapeutics Inc
15/04/201922h30GlobeNewswire Inc.Intellia Therapeutics Announces Three Oral Presentations on In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeti...NASDAQ:NTLAIntellia Therapeutics Inc
25/03/201919h21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h41Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h39Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h00Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201912h30GlobeNewswire Inc.Intellia Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
14/02/201922h05Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:NTLAIntellia Therapeutics Inc
24/01/201913h00GlobeNewswire Inc.Intellia Therapeutics Names Fred Cohen, M.D., to Board of DirectorsNASDAQ:NTLAIntellia Therapeutics Inc
20/12/201822h18Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NTLAIntellia Therapeutics Inc
06/12/201813h30GlobeNewswire Inc.Intellia Therapeutics and Novartis Expand Cell Therapy Collaboration to Pursue CRISPR/Cas9-based Genome Editing in Additional...NASDAQ:NTLAIntellia Therapeutics Inc
08/11/201822h30GlobeNewswire Inc.Intellia Therapeutics to Present at November Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
31/10/201812h30GlobeNewswire Inc.Intellia Therapeutics Announces Third Quarter 2018 Financial Results and Corporate DevelopmentsNASDAQ:NTLAIntellia Therapeutics Inc
30/10/201821h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2018 Earnings and Corporate DevelopmentsNASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA

Dernières Valeurs Consultées

EU
AI
Air Liquide
NASDAQ
NVDA
NVIDIA
NASDAQ
AMZN
Amazon.com
NYSE
JPM
JP Morgan Chase
EU
VIV
Vivendi
NYSE
MCD
McDonalds
EU
SGO
Cie de SaintGobain
EU
HO
Thales
SPI
SP500
S&P 500
COIN
BTCUSD
Bitcoin
COIN
ETHUSD
Ethereum
EU
EN
Bouygues
EU
ML
Michelin
EU
VK
Vallourec
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés